2.Dapsone hypersensitivity syndrome.
Qing ZHAO ; Lele SUN ; Yonghu SUN ; Dean NAISBITT ; Hong LIU ; Furen ZHANG
Chinese Medical Journal 2023;136(13):1560-1562
3.Dupilumab for Treatment of Food-Dependent, Exercise-Induced Anaphylaxis: Report of One Case.
Li-Ping ZHU ; Rui TANG ; Qing WANG ; Hong LI
Chinese Medical Sciences Journal 2023;38(2):159-162
		                        		
		                        			
		                        			Food-dependent, exercise-induced anaphylaxis (FDEIA) is a potentially life-threatening disorder that often occurs with exercise, and patients typically have eaten a specific food within hours before disease onset. This disease is exceedingly rare, with a prevalence of 0.02%. No well-recognized prevention or treatment strategy has been available for FDEIA except avoiding triggers strictly. Here we report an 11-year-old boy with a history of recurrent anaphylaxis of unknown etiology more than 10 times within two years. As the anaphylactic symptoms had not been controlled after traditional treatments, the patient was given subcutaneous injection of dupilumab seven times within 33 weeks. During dupilumab treatments, the patient was exposed to culprit mushrooms plus exercises at least twice a month but without notable anaphylaxis. Thus, Dupilumab may improve the allergic reactions in FDEIA patients.
		                        		
		                        		
		                        		
		                        			Male
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Anaphylaxis/etiology*
		                        			;
		                        		
		                        			Food Hypersensitivity/diagnosis*
		                        			;
		                        		
		                        			Exercise-Induced Allergies
		                        			;
		                        		
		                        			Antibodies, Monoclonal, Humanized/therapeutic use*
		                        			
		                        		
		                        	
4.Association between acute adverse reactions to iodinated contrast media and anxiety in patients undergoing contrast-enhanced CT examination.
Journal of Central South University(Medical Sciences) 2023;48(8):1225-1233
		                        		
		                        			OBJECTIVES:
		                        			As the use of iodinated contrast media has become more widely with advances in imaging, several guidelines have suggested that anxiety increases the risk of acute adverse reactions associated with iodinated contrast media. This study aims to evaluate the impact of anxiety on the occurrence of acute adverse reactions (AAR) to iodinated contrast media in patients undergoing contrast-enhanced CT examinations.
		                        		
		                        			METHODS:
		                        			Inpatients who underwent contrast-enhanced CT examinations at the Third Xiangya Hospital between February and October 2021 were prospectively recruited. Prior to the imaging examinations, all patients completed the Generalized Anxiety Disorder Scale-7 (GAD-7) assessment before the imaging examinations to determine the severity of anxiety, which was categorized as mild, moderate, or severe. Based on the occurrence of AAR, patients were classified into an AAR group and a non-AAR group. The difference in anxiety was compared between the 2 groups. Multivariate logistic regression analysis was used to identify independent risk factors associated with AAR. To ensure comparability between the 2 groups, propensity score matching (PSM) was utilized to align the clinical characteristics. Subsequently, the difference in anxiety within the matched groups was analyzed.
		                        		
		                        			RESULTS:
		                        			The study comprised 880 patients, with 80 patients in the AAR group and 800 patients in the non-AAR group. There was a significant difference in proportion of patients with mild-severe anxiety between the 2 groups (75% in the AAR group and 36% in the non-AAR group, P<0.001). Additionally, differences were also observed in occupation, income, underlying diseases, and allergy history (all P<0.001). The results of multivariate logistic regression analysis revealed that patients' income, allergy history, and anxiety were independent risk factors for AAR to iodinated contrast media (all P<0.05). Following PSM, each matched group included 66 cases, and no significant differences in clinical characteristics were observed between the 2 groups (all P>0.05). However, the proportion of patients with mild-severe anxiety remained significantly higher in the AAR group compared to the non-AAR group (75% in the AAR group and 31% in the non-AAR group, P<0.001).
		                        		
		                        			CONCLUSIONS
		                        			Anxiety is associated with an increased risk of AAR to iodinated contrast media in patients undergoing contrast-enhanced CT examinations, suggesting the clinical importance of screening for anxiety before imaging examinations.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Contrast Media/adverse effects*
		                        			;
		                        		
		                        			Tomography, X-Ray Computed/methods*
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Anxiety
		                        			;
		                        		
		                        			Hypersensitivity/etiology*
		                        			;
		                        		
		                        			Retrospective Studies
		                        			
		                        		
		                        	
5.Clinical characteristics of IgE-mediated cow's milk protein allergy in children.
Xiao Yang WANG ; Ming Jun SHAO ; Yu Fan WANG ; Yu Yang DU ; Shi Qiu XIONG ; Li SHA ; Chuan He LIU
Chinese Journal of Pediatrics 2022;60(5):447-451
		                        		
		                        			
		                        			Objective: To analyze the clinical features of IgE-mediated cow's milk protein allergy (CMPA) in children aged 0-5 years. Methods: This cross-sectional study collected the data on children diagnosed with CMPA in the Department of Allergy at the Children's Hospital of the Capital Institute of Pediatrics from October 2019 to November 2020 and improved peripheral blood routine,total IgE defection, milk specific IgE (sIgE) defection,SPT and milk component defection,diagnosis of severe anaphylaxis based on clinical manifestations. Rank-sum test and chi-square test are used for statistical analysis of clinical characteristics between groups. Results: A total of 106 children (67 boys and 39 girls) were enrolled with the age of 15 (8, 34) months, including 42 cases (≤ 1 year of age), 39 cases (>1-<3 years of age) and 25 cases(≥3 years of age), the onset age of 6 (5, 8) months. Among them, 95 cases (89.6%) were reacted after consuming milk or its products, 42 cases (39.6%) had reaction due to skin contact and 11 cases (10.4%) reacted after exclusive breastfeeding. The onset time of milk product consumption was 45 (1, 120) min, skin contact pathway was 10 (5, 30) min and symptoms in breastfeeding pathway was 121 (61, 180) min. There was statistical difference among the time of symptoms (χ2=77.01, P<0.001).The cutaneous reaction was most common (100 cases, 94.3%), followed by digestive (20 cases, 18.9%) and respiratory (16 cases, 15.1%), and the nervous symptoms (1 case, 0.9%) were uncommon and 24 cases (22.6%) had at least one episode of anaphylaxis. There were 87 cases (82.1%) also diagnosed with other food allergies, 94 cases (88.7%) with previous eczema, 57 cases (53.8%) with history of rhinitis, and 23 cases (21.7%) with history of wheezing. The total IgE level was 191.01 (64.71, 506.80) kU/L, and the cow's milk sIgE level was 3.03 (1.11, 15.24) kU/L. The maximum diameter of the wheal in SPT was 8.2 (4.0, 12.0) mm. Component resolved diagnosis showed that 77 cases (81.9%) were sensitized to at least one out of 4 main components, including casein, α lactalbumin, β lactoglobulin and bovine serum albumin.The possibility of anaphylaxis in children with milk sIgE grade Ⅳ-Ⅵ was higher than that in children with grade 0-Ⅲ (57.7% (15/26) vs. 12.5% (10/80), OR=9.545, 95%CI 3.435-26.523). Children with milk SPT ≥+++ had a higher probability of anaphylaxis than those with milk SPT ≤++ (34.4% (11/32) vs. 11.5% (3/26), OR=4.016, 95%CI 0.983-16.400). Anaphylaxis were more common in α lactalbumin positive children than in negative children (34.3% (13/38) vs. 14.2% (8/56), χ2=1.23,P=0.042). Conclusions: CMPA in children has early onset and diversified clinical manifestations, which are mainly cutaneous symptoms. Most children are sensitized to at least one allergen component. Serum sIgE level, SPT reaction and allergen components play important roles in the diagnosis and evaluation of CMPA, and higher milk sIgE level may predict a higher risk of anaphylaxis.
		                        		
		                        		
		                        		
		                        			Allergens
		                        			;
		                        		
		                        			Anaphylaxis/etiology*
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Cattle
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Cross-Sectional Studies
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunoglobulin E
		                        			;
		                        		
		                        			Lactalbumin
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Milk Hypersensitivity/diagnosis*
		                        			;
		                        		
		                        			Skin Tests
		                        			
		                        		
		                        	
7.Research progress on adverse reactions and pseudo-allergic reactions of traditional Chinese medicine injections.
Yan YI ; Chun-Ying LI ; Yong ZHAO ; Ai-Hua LIANG
China Journal of Chinese Materia Medica 2021;46(7):1711-1716
		                        		
		                        			
		                        			Since the safety re-evaluation of traditional Chinese medicine(TCM) injections began in 2009, some TCM injection companies and research institutes have done a lot of work. And with the increase of drug development and drug production technology levels in China, the safety of some TCM injections has been greatly improved. There are safety risks in TCM injections, which are mainly reflected in unclear basis of medicinal materials, simple production process, poor controllability of quality standards, nonstan-dard drug instructions and irrational medication in the use process. This paper describes the research progress of the above-mentioned aspects of TCM injections. In addition, the author team found that adverse reactions of TCM injections are mainly pseudo-allergic reactions. Therefore, a lot of work has been done in detection of pseudo-allergic reactions, mechanism research and risk control. This part of the work is also described in this article.
		                        		
		                        		
		                        		
		                        			China
		                        			;
		                        		
		                        			Drugs, Chinese Herbal/adverse effects*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypersensitivity/etiology*
		                        			;
		                        		
		                        			Injections
		                        			;
		                        		
		                        			Medicine, Chinese Traditional/adverse effects*
		                        			
		                        		
		                        	
8.Hokkaido birth cohort study on environment and children's health: cohort profile 2021.
Reiko KISHI ; Atsuko IKEDA-ARAKI ; Chihiro MIYASHITA ; Sachiko ITOH ; Sumitaka KOBAYASHI ; Yu AIT BAMAI ; Keiko YAMAZAKI ; Naomi TAMURA ; Machiko MINATOYA ; Rahel Mesfin KETEMA ; Kritika POUDEL ; Ryu MIURA ; Hideyuki MASUDA ; Mariko ITOH ; Takeshi YAMAGUCHI ; Hisanori FUKUNAGA ; Kumiko ITO ; Houman GOUDARZI
Environmental Health and Preventive Medicine 2021;26(1):59-59
		                        		
		                        			BACKGROUND:
		                        			The Hokkaido Study on Environment and Children's Health is an ongoing study consisting of two birth cohorts of different population sizes: the Sapporo cohort and the Hokkaido cohort. Our primary objectives are to (1) examine the effects that low-level environmental chemical exposures have on birth outcomes, including birth defects and growth retardation; (2) follow the development of allergies, infectious diseases, and neurobehavioral developmental disorders, as well as perform a longitudinal observation of child development; (3) identify high-risk groups based on genetic susceptibility to environmental chemicals; and (4) identify the additive effects of various chemicals, including tobacco.
		                        		
		                        			METHODS:
		                        			The purpose of this report is to provide an update on the progress of the Hokkaido Study, summarize recent results, and suggest future directions. In particular, this report provides the latest details from questionnaire surveys, face-to-face examinations, and a collection of biological specimens from children and measurements of their chemical exposures.
		                        		
		                        			RESULTS:
		                        			The latest findings indicate different risk factors of parental characteristics on birth outcomes and the mediating effect between socioeconomic status and children that are small for the gestational age. Maternal serum folate was not associated with birth defects. Prenatal chemical exposure and smoking were associated with birth size and growth, as well as cord blood biomarkers, such as adiponectin, leptin, thyroid, and reproductive hormones. We also found significant associations between the chemical levels and neuro development, asthma, and allergies.
		                        		
		                        			CONCLUSIONS
		                        			Chemical exposure to children can occur both before and after birth. Longer follow-up for children is crucial in birth cohort studies to reinforce the Developmental Origins of Health and Disease hypothesis. In contrast, considering shifts in the exposure levels due to regulation is also essential, which may also change the association to health outcomes. This study found that individual susceptibility to adverse health effects depends on the genotype. Epigenome modification of DNA methylation was also discovered, indicating the necessity of examining molecular biology perspectives. International collaborations can add a new dimension to the current knowledge and provide novel discoveries in the future.
		                        		
		                        		
		                        		
		                        			Biomarkers/blood*
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Child Health
		                        			;
		                        		
		                        			Child, Preschool
		                        			;
		                        		
		                        			Cohort Studies
		                        			;
		                        		
		                        			Environmental Exposure/adverse effects*
		                        			;
		                        		
		                        			Environmental Health
		                        			;
		                        		
		                        			Environmental Pollutants/adverse effects*
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Fetal Blood/chemistry*
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Growth/drug effects*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypersensitivity/etiology*
		                        			;
		                        		
		                        			Infant
		                        			;
		                        		
		                        			Japan/epidemiology*
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Neurodevelopmental Disorders/etiology*
		                        			;
		                        		
		                        			Pregnancy
		                        			;
		                        		
		                        			Prenatal Exposure Delayed Effects/etiology*
		                        			;
		                        		
		                        			Prevalence
		                        			;
		                        		
		                        			Smoking/adverse effects*
		                        			
		                        		
		                        	
9.Lifestyle behaviors and home and school environment in association with sick building syndrome among elementary school children: a cross-sectional study.
Rahel Mesfin KETEMA ; Atsuko ARAKI ; Yu AIT BAMAI ; Takeshi SAITO ; Reiko KISHI
Environmental Health and Preventive Medicine 2020;25(1):28-28
		                        		
		                        			BACKGROUND:
		                        			Sick building syndrome (SBS) refers to the combination of symptoms experienced by occupants of specific building characteristics. This study investigated the associations of children's lifestyle behaviors, allergies, home, and school environment with SBS symptoms.
		                        		
		                        			METHODS:
		                        			A total of 4408 elementary school children living in Sapporo City, Japan participated in this study. SBS was determined on parental answers to MM080 standardized school questionnaires on symptoms that were weekly experienced by these children, and if the symptom is attributed to their home or school environment. The Japanese version of the International Study of Asthma and Allergies in Childhood questionnaire was used to assess wheeze, rhino-conjunctivitis, and eczema. A logistic regression analysis was conducted to evaluate the associations between SBS symptoms and variables by controlling the potential confounders (gender, grade, school, and parental history of allergies). A stepwise backward elimination was conducted to assess independent variables related to SBS.
		                        		
		                        			RESULTS:
		                        			Participants revealed mucosal (6.9%), skin (2.0%), and general (0.8%) symptoms. The presence of one or more allergy was associated with increased mucosal and skin symptoms. Children who skipped breakfast, displayed faddiness (like/dislike of food), had constipation, have insufficient sleep, did not feel refreshed after sleep, and lacked deep sleep showed significantly high odds ratios with SBS symptoms. The stepwise analysis showed faddiness for mucosal symptoms and not feeling refreshed after sleep for mucosal and skin symptoms, whereas constipation and lacking deep sleep for general symptoms were independent variables in increasing the symptoms. We found no significant relationship between SBS in children and schools. Considering children's home, old building, no ventilation, wall-to-wall carpet, and heavy nearby traffic were associated with elevated mucosal symptom, while living in a multifamily home increased general symptoms. Home dampness was an independent variable in increasing all SBS symptoms.
		                        		
		                        			CONCLUSIONS
		                        			Allergies and lifestyle behaviors were associated with increased SBS in children, including skipping breakfast, displaying faddiness, constipation, insufficient sleep, not feeling refreshed after sleep, and the lack of deep sleep. Further, dampness at home was associated with increase in all SBS symptoms. Lifestyle (e.g., eating and sleeping habits) and home (i.e., dampness) improvements might alleviate SBS symptoms in children.
		                        		
		                        		
		                        		
		                        			Child
		                        			;
		                        		
		                        			Cross-Sectional Studies
		                        			;
		                        		
		                        			Environment
		                        			;
		                        		
		                        			Housing
		                        			;
		                        		
		                        			statistics & numerical data
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypersensitivity
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			etiology
		                        			;
		                        		
		                        			Japan
		                        			;
		                        		
		                        			Life Style
		                        			;
		                        		
		                        			Prevalence
		                        			;
		                        		
		                        			Schools
		                        			;
		                        		
		                        			statistics & numerical data
		                        			;
		                        		
		                        			Sick Building Syndrome
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			etiology
		                        			;
		                        		
		                        			Students
		                        			;
		                        		
		                        			statistics & numerical data
		                        			
		                        		
		                        	
10.Cumulative inactivated vaccine exposure and allergy development among children: a birth cohort from Japan.
Kiwako YAMAMOTO-HANADA ; Kyongsun PAK ; Mayako SAITO-ABE ; Limin YANG ; Miori SATO ; Hidetoshi MEZAWA ; Hatoko SASAKI ; Minaho NISHIZATO ; Mizuho KONISHI ; Kazue ISHITSUKA ; Kenji MATSUMOTO ; Hirohisa SAITO ; Yukihiro OHYA
Environmental Health and Preventive Medicine 2020;25(1):27-27
		                        		
		                        			BACKGROUND:
		                        			Adjuvants used in inactivated vaccines often upregulate type 2 immunity, which is dominant in allergic diseases. We hypothesised that cumulative adjuvant exposure in infancy may influence the development of allergies later in life by changing the balance of type 1/type 2 immunity. We examined the relationship between immunisation with different vaccine types and later allergic disease development.
		                        		
		                        			METHODS:
		                        			We obtained information regarding vaccinations and allergic diseases through questionnaires that were used in The Japan Environment and Children's Study (JECS), which is a nationwide, multicentre, prospective birth cohort study that included 103,099 pregnant women and their children. We examined potential associations between the initial vaccination before 6 months of age and symptoms related to allergies at 12 months of age.
		                        		
		                        			RESULTS:
		                        			Our statistical analyses included 56,277 children. Physician-diagnosed asthma was associated with receiving three (aOR 1.395, 95% CI 1.028-1.893) or four to five different inactivated vaccines (aOR 1.544, 95% CI 1.149-2.075), compared with children who received only one inactivated vaccine. Similar results were found for two questionnaire-based symptoms, i.e. wheeze (aOR 1.238, 95% CI 1.094-1.401; three vaccines vs. a single vaccine) and eczema (aOR 1.144, 95% CI 1.007-1.299; four or five vaccines vs. a single vaccine).
		                        		
		                        			CONCLUSIONS:
		                        			Our results, which should be cautiously interpreted, suggest that the prevalence of asthma, wheeze and eczema among children at 12 months of age might be related to the amount of inactivated vaccine exposure before 6 months of age. Future work should assess if this association is due to cumulative adjuvant exposure. Despite this possible association, we strongly support the global vaccination strategy and recommend that immunisations continue.
		                        		
		                        			TRIAL REGISTRATION
		                        			UMIN000030786 .
		                        		
		                        		
		                        		
		                        			Asthma
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			etiology
		                        			;
		                        		
		                        			Cohort Studies
		                        			;
		                        		
		                        			Dermatitis, Atopic
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			etiology
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Food Hypersensitivity
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			etiology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypersensitivity
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			etiology
		                        			;
		                        		
		                        			Infant
		                        			;
		                        		
		                        			Infant, Newborn
		                        			;
		                        		
		                        			Japan
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Vaccines, Inactivated
		                        			;
		                        		
		                        			adverse effects
		                        			;
		                        		
		                        			Viral Vaccines
		                        			;
		                        		
		                        			adverse effects
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail